发明名称 ANTHRANILIC ACID AMIDES AND PHARMACEUTICAL USE THEREOF
摘要 The invention relates to anthranilic acid amide derivatives of formula (I), wherein Ar is represented by the subformula (Ia), wherein Ra represents H or lower alkyl, and R1 represents H or perfluoro lower alkyl, R2 represents H, halogen, C2-C7alkyl, C2-C7alkenyl or lower aklynyl; or Ar is represented by the subformula (Ib) and R1 represents perfluoro lower alkyl, and R2 represents bromo, iodo, C2-C7alkyl, C2-C7alkenyl or lower alkynyl, or R1 represents H, and R2 represents fluoro, bromo, iodo, ethyl, C5-C7alkyl, C2-C7alkenyl or lower alkynyl; to N-oxides and tautomers thereof, and to salts of such anthranilic acid amides, its N-oxides and tautomers; to processes for their preparation; to their application in the treatment of the human or animal body, to the use thereof - alone or in combination with one or more other pharmaceutically active compounds - for the treatment especially of a neoplastic disease, such as a tumor disease, of retinopathy or age-related macular degeneration; to a method for the treatment of such diseases in animals; and to the use of such a compound - alone or in combination with one or more other pharmaceutically active compounds - for the manufacture of a pharmaceutical preparation for the treatment of a neoplastic disease, of retinopathy or age-related macular degeneration.
申请公布号 CA2462390(C) 申请公布日期 2011.01.11
申请号 CA20022462390 申请日期 2002.11.07
申请人 NOVARTIS AG 发明人 BOLD, GUIDO;FURET, PASCAL;MANLEY, PAUL WILLIAM
分类号 C07D213/38;A61K31/165;A61K31/166;A61K31/44;A61K31/4409;A61P3/10;A61P9/10;A61P11/06;A61P15/00;A61P17/06;A61P19/02;A61P27/00;A61P27/06;A61P29/00;A61P35/00;A61P35/02;C07C231/12;C07C237/40;C07D213/89 主分类号 C07D213/38
代理机构 代理人
主权项
地址